Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia
This report provides summarised updates on adverse events following immunisation (AEFIs) of COVID-19 Vaccines in Malaysia.
To receive the latest issues of MADRAC Bulletin, you may join the NPRA Safety Information Mailing List by emailing details of your name, profession and workplace to fv@npra.gov.my (please put in NPRA Safety Mailing List as the subject of your email) OR filling out the subscription form at https://forms.gle/x7eim2Z99HKVNSsz6.
The summary report is only available in English.
Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 29th October 2021)
Introduction
- How NPRA collects adverse event reports?
- How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines?
Total Doses of Covid-19 Vaccine Administered
Rate of Reported Adverse Events
- AEFI responses received via MySejahtera Application
- AEFI reports received via NPRA Reporting System
Summary
- Protective benefits of COVID-19 vaccination outweigh the potential risks
